Growth Metrics

Bio-Rad Laboratories (BIO-B) Cash from Operations Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Bio-Rad Laboratories - - 309.40 Mn -16.78%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -16.78%
Dec 31, 2025 32.77%
Sep 30, 2025 -26.10%
Jun 30, 2025 19.36%
Mar 31, 2025 86.10%
Dec 31, 2024 53.33%
Sep 30, 2024 67.43%
Jun 30, 2024 -0.48%
Mar 31, 2024 -28.86%
Dec 31, 2023 1.75%
Sep 30, 2023 789.09%
Jun 30, 2023 83.99%
Mar 31, 2023 94.30%
Dec 31, 2022 -53.42%
Sep 30, 2022 -95.23%
Jun 30, 2022 -65.52%
Mar 31, 2022 -55.55%
Dec 31, 2021 -41.94%
Sep 30, 2021 69.82%
Jun 30, 2021 67.81%
Mar 31, 2021 80.88%
Dec 31, 2020 84.21%
Sep 30, 2020 35.95%
Jun 30, 2020 -40.72%
Mar 31, 2020 46.41%
Dec 31, 2019 52.18%
Sep 30, 2019 60.24%
Jun 30, 2019 99.58%
Mar 31, 2019 6.33%
Dec 31, 2018 51.47%
Sep 30, 2018 118.71%
Jun 30, 2018 24.59%
Mar 31, 2018 171.79%
Dec 31, 2017 -26.86%
Sep 30, 2017 -44.82%
Jun 30, 2017 -19.00%
Mar 31, 2017 -654.56%
Dec 31, 2016 163.72%
Sep 30, 2016 -37.28%
Jun 30, 2016 100.23%
Mar 31, 2016 -125.29%
Dec 31, 2015 -10.60%
Sep 30, 2015 -9.24%
Jun 30, 2015 -49.87%
Mar 31, 2015 -55.09%
Dec 31, 2014 -42.98%
Sep 30, 2014 65.33%
Jun 30, 2014 289.48%
Mar 31, 2014 173.01%
Dec 31, 2013 -18.23%
Sep 30, 2013 -23.14%
Jun 30, 2013 -73.20%
Mar 31, 2013 -31.89%
Dec 31, 2012 5.82%
Sep 30, 2012 39.45%
Jun 30, 2012 -33.23%
Mar 31, 2012 78.24%
Dec 31, 2011 -18.82%
Sep 30, 2011 -23.49%
Jun 30, 2011 203.14%
Mar 31, 2011 -11.17%
Dec 31, 2010 -13.25%
Sep 30, 2010 -31.41%